Long-term methylglyoxal treatment causes endothelial dysfunction of rat isolated mesenteric artery

Journal of Veterinary Medical Science

Volumn 75, Issue 2, 2013, Pages 151-157

  Mukohda, Masashi ^a   Morita, Tomoka ^a   Okada, Muneyoshi ^a   Hara, Yukio ^a   Yamawaki, Hideyuki ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Endothelium dependent relaxation; Methylglyoxal; Organ culture; Reactive oxygen species

Indexed keywords

ACETYLCHOLINE; ACTIN; METHYLGLYOXAL; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL; ARTICLE; DRUG EFFECT; MALE; MESENTERIC ARTERY; PHYSIOLOGY; RAT; VASCULAR ENDOTHELIUM; WISTAR RAT;

ACETYLCHOLINE; ACTINS; ANIMALS; ENDOTHELIUM, VASCULAR; MALE; MESENTERIC ARTERIES; NITRIC OXIDE; NITROPRUSSIDE; PYRUVALDEHYDE; RATS; RATS, WISTAR;

EID: 84874677726     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.12-0345     Document Type: Article

References (28)

1. Ahmed, M. U., Brinkmann Frye, E., Degenhardt, T. P., Thorpe, S. R. and Baynes, J. W. 1997. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem. J. 324 565-570.
2. Aizawa, T., Wei, H., Miano, J. M., Abe, J., Berk, B. C. and Yan, C. 2003. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Circ. Res. 93: 406-413.
3. Brouwers, O., Niessen, P. M., Haenen, G., Miyata, T., Brownlee, M., Stehouwer, C. D., De Mey, J. G. and Schalkwijk, C. G. 2010. Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia 53: 989-1000.
4. Desai, K. M., Chang, T., Wang, H., Banigesh, A., Dhar, A., Liu, J., Untereiner, A. and Wu, L. 2010. Oxidative stress and aging: is methylglyoxal the hidden enemy? Can. J. Physiol. Pharmacol. 88: 273-284.
5. Dhar, A., Dhar, I., Desai, K. M. and Wu, L. 2010. Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose. Br. J. Pharmacol. 161: 1843-1856.
6. Fosmark, D. S., Torjesen, P. A., Kilhovd, B. K., Berg, T. J., Sandvik, L., Hanssen, K. F., Agardh, C. D. and Agardh, E. 2006. Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus. Metabolism 55: 232-236.
7. Guo, Q., Mori, T., Jiang, Y., Hu, C., Osaki, Y., Yoneki, Y., Sun, Y., Hosoya, T., Kawamata, A., Ogawa, S., Nakayama, M., Miyata, T. and Ito, S. 2009. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats. J. Hypertens. 27: 1664-1671.
8. Lapolla, A., Flamini, R., Dalla Vedova, A., Senesi, A., Reitano, R., Fedele, D., Basso, E., Seraglia, R. and Traldi, P. 2003. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin. Chem. Lab. Med. 41: 1166-1173.
9. McLellan, A. C., Thornalley, P. J., Benn, J. and Sonksen, P. H. 1994. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. (Lond.) 87: 21-29.
10. Morita, T., Okada, M., Hara, Y. and Yamawaki, H. 2011. Mechanisms underlying impairment of endothlium-dependent relaxation by fetal bovine serum in organ-cultured rat mesenteric artery. Eur. J. Pharmacol. 668: 401-406.
11. Morita, T., Yamawaki, H., Okada, M. and Hara, Y. 2010. Contractile characteristics of rat mesenteric artery after organ culture. J. Vet. Med. Sci. 72: 1621-1627.
12. Mostafa, A. A., Randell, E. W., Vasdev, S. C., Gill, V. D., Han, Y., Gadag, V., Raouf, A. A. and El Said, H. 2007. Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes. Mol. Cell. Biochem. 302: 35-42.
13. Mukohda, M., Morita, T., Okada, M., Hara, Y. and Yamawaki, H. 2012. Long-term methylglyoxal treatment impairs smooth muscle contractility in organ-cultured rat mesenteric artery. Pharmacol. Res. 65: 91-99.
14. Mukohda, M., Yamawaki, H., Nomura, H., Okada, M. and Hara, Y. 2009. Methylglyoxal inhibits smooth muscle contraction in isolated blood vessels. J. Pharmacol. Sci. 109: 305-310.
15. Mukohda, M., Yamawaki, H., Okada, M. and Hara, Y. 2010. Methylglyoxal augments angiotensin II-induced contraction in rat isolated carotid artery. J. Pharmacol. Sci. 114: 390-398.
16. Mukohda, M., Yamawaki, H., Okada, M. and Hara, Y. 2010. Methylglyoxal enhances sodium nitroprusside-induced relaxation in rat aorta. J. Pharmacol. Sci. 112: 176-183.
17. Mukohda, M., Okada, M., Hara, Y. and Yamawaki, H. 2012. Methylglyoxal accumulation in arterial walls causes vascular contractile dysfunction in spontaneously hypertensive rats. J. Pharmacol. Sci. 120: 26-35.
18. Odani, H., Shinzato, T., Matsumoto, Y., Usami, J. and Maeda, K. 1999. Increase in three alpha, beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochem. Biophys. Res. Commun. 256: 89-93.
19. Oya, T., Hattori, N., Mizuno, Y., Miyata, S., Maeda, S., Osawa, T. and Uchida, K. 1999. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J. Biol. Chem. 274: 18492-18502.
20. Schalkwijk, C. G., van Bezu, J., van der Schors, R. C., Uchida, K., Stehouwer, C. D. and van Hinsbergh, V. W. 2006. Heat-shock protein 27 is a major methylglyoxal-modified protein in endothelial cells. FEBS Lett. 580: 1565-1570.
21. Vasdev, S., Ford, C. A., Longerich, L., Parai, S., Gadag, V. and Wadhawan, S. 1998. Aldehyde induced hypertension in rats: prevention by N-acetyl cysteine. Artery 23: 10-36.
22. Wang, X., Desai, K., Chang, T. and Wu, L. 2005. Vascular methylglyoxal metabolism and the development of hypertension. J. Hypertens. 23: 1565-1573.
23. Wang, X., Desai, K., Clausen, J. T. and Wu, L. 2004. Increased methylglyoxal and advanced glycation end products in kidney from spontaneously hypertensive rats. Kidney Int. 66: 2315-2321.
24. Williams, H. C. and Griendling, K. K. 2007. NADPH oxidase inhibitors: new antihypertensive agents? J. Cardiovasc. Pharmacol. 50: 9-16.
25. Wu, L. 2006. Is methylglyoxal a causative factor for hypertension development? Can. J. Physiol. Pharmacol. 84: 129-139.
26. Yamawaki, H. and Hara, Y. 2008. Glyoxal causes inflammatory injury in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 369: 1155-1159.
27. Yamawaki, H., Saito, K., Okada, M. and Hara, Y. 2008. Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells. Am. J. Physiol. Cell Physiol. 295: C1510-C1517.
28. Yim, H. S., Kang, S. O., Hah, Y. C., Chock, P. B. and Yim, M. B. 1995. Free radicals generated during the glycation reaction of amino acids by methylglyoxal. A model study of proteincross-linked free radicals. J. Biol. Chem. 270: 28228-28233.